The placebo response: Science versus ethics and the vulnerability of the patient

World Psychiatry

Volumn 11, Issue 2, 2012, Pages 70-72

  Benedetti, Fabrizio ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; CANNABINOID; CHOLECYSTOKININ; DOPAMINE; MORPHINE; NEUROTRANSMITTER; OPIATE;

DRUG BINDING; ETHICS; HUMAN; MOTOR DYSFUNCTION; NEUROIMAGING; NEUROPHARMACOLOGY; PAIN; PLACEBO EFFECT; PRIORITY JOURNAL; REVIEW; SCIENCE; SOCIAL INTERACTION; TRADITIONAL HEALER;

EID: 84871288227     PISSN: 17238617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.wpsyc.2012.05.003     Document Type: Editorial

References (15)

1. Benedetti F. Placebo effects: understanding the mechanisms in health and disease. Oxford: Oxford University Press, 2008.
2. Benedetti F, Carlino E, Pollo A. How placebos change the patient's brain. Neuropsychopharmacol Rev 2011;36:339-54.
3. Finniss DG, Kaptchuk TJ, Miller F et al. Biological, clinical, and ethical advances of placebo effects. Lancet 2010;375:686-95.
4. Eippert F, Bingel U, Schoell ED et al. Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron 2009;63:533-43.
5. Benedetti F, Amanzio M, Rosato R et al. Non-opioid placebo analgesia is mediated by CB1 cannabinoid receptors. Nature Med 2011;17:1228-30.
6. Benedetti F, Amanzio M, Thoen W. Disruption of opioid-induced placebo responses by activation of cholecystokinin type-2 receptors. Psychopharmacology 2011;213:791-7.
7. Scott DJ, Stohler CS, Egnatuk CM et al. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch Gen Psychiatry 2008;65:220-31.
8. Tracey I. Getting the pain you expect: mechanisms of placebo, nocebo and reappraisal effects in humans. Nature Med 2010;16:1277-83.
9. Benedetti F. Mechanisms of placebo and placebo-related effects across diseases and treatments. Annu Rev Pharmacol Toxicol 2008; 48:33-60.
10. Colloca L, Lopiano L, Lanotte M et al. Overt versus covert treatment for pain, anxiety and Parkinson's disease. Lancet Neurol 2004;3:679- 84.
11. Benedetti F, Carlino E, Pollo A. Hidden administration of drugs. Clin Pharmacol Ther 2011;90:651-61.
12. Bingel U, Wanigasekera V, Wiech K et al. The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil. Science Transl Med 2011;3:70-14.
13. Benedetti F. The patient's brain: the neuroscience behind the doctorpatient relationship. Oxford: Oxford University Press, 2010.
14. Miller FG, Colloca L. The legitimacy of placebo treatments in clinical practice: evidence and ethics. Am J Bioeth 2009;9:39-47.
15. Miller FG, Colloca L. The placebo phenomenon and medical ethics: rethinking the relationship between informed consent and riskbenefit assessment. Theor Med Bioeth 2011;32:229-43.